Heart failure with reduced ejection fraction: a review

SP Murphy, NE Ibrahim, JL Januzzi - Jama, 2020 - jamanetwork.com
Importance Worldwide, the burden of heart failure has increased to an estimated 23 million
people, and approximately 50% of cases are HF with reduced ejection fraction (HFrEF) …

Management of arrhythmias in cardiac amyloidosis

S Giancaterino, MA Urey, D Darden, JC Hsu - Clinical Electrophysiology, 2020 - jacc.org
Cardiac amyloidosis is characterized by extracellular protein fibril deposition in the
myocardium leading to restrictive heart failure. Both atrial and ventricular arrhythmias, along …

Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study

JB Augusto, R Eiros, E Nakou… - European Heart …, 2020 - academic.oup.com
Aims Myocardial scar detected by cardiovascular magnetic resonance has been associated
with sudden cardiac death in dilated cardiomyopathy (DCM). Certain genetic causes of DCM …

Sacubitril/valsartan and sudden cardiac death according to implantable cardioverter-defibrillator use and heart failure cause: a PARADIGM-HF analysis

LE Rohde, NA Chatterjee, M Vaduganathan… - Heart Failure, 2020 - jacc.org
Objectives The purpose of this study was to investigate the effect of sacubitril/valsartan
therapy on sudden cardiac death (SCD) according to the use of and eligibility for an …

Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

M Zabel, R Willems, A Lubinski, A Bauer… - European heart …, 2020 - academic.oup.com
Abstract Aims The EUropean Comparative Effectiveness Research to Assess the Use of
Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective …

What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?

M Packer - European Heart Journal, 2020 - academic.oup.com
Sudden death characterizes the mode of demise in 30–50% of patients with chronic heart
failure and a reduced ejection fraction. Occasionally, these events have an identifiable …

Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure: CASTLE-AF trial

C Sohns, K Zintl, Y Zhao, L Dagher… - Circulation …, 2020 - Am Heart Assoc
Background: Recent data demonstrate promising effects on left ventricular dysfunction and
left ventricular ejection fraction (LVEF) improvement following ablation for atrial fibrillation …

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) …

JC Nielsen, YJ Lin, MJ de Oliveira Figueiredo… - Ep …, 2020 - academic.oup.com
Patients with cardiac diseases or conditions with high risk of developing cardiac diseases
undergo risk assessment by cardiologists, primary care physicians, and scientists based on …

Prognostic value of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy: an international, multi-institutional study of …

AC Alba, J Gaztañaga, F Foroutan… - Circulation …, 2020 - Am Heart Assoc
Background: Dilated cardiomyopathy is associated with increased risk of major
cardiovascular events. Late gadolinium enhancement (LGE) cardiac magnetic resonance …

Long-term outcomes of implantable cardioverter-defibrillator therapy in the SCD-HeFT

JE Poole, B Olshansky, DB Mark, J Anderson… - Journal of the American …, 2020 - jacc.org
Abstract Background The SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
randomized 2,521 patients with moderate heart failure (HF) to amiodarone, placebo drug, or …